PPARγ disease gene network and identification of therapeutic targets for prostate cancer

QR Code

PPARγ disease gene network and identification of therapeutic targets for prostate cancer

Peroxisome proliferator-activated receptor (PPAR) belongs to the nuclear hormone receptor superfamily. Recently published reports demonstrate the importance of a direct repeat 2 (DR2) as a PPARγ-responsive element in addition to the canonical direct repeat 1 (DR1) Peroxisome proliferator response el...

Full description

Bibliographic Details
Main Authors:	Venkatachalam, G., Kumar, Alan Prem, Sakharkar, K., Thangavel, S., Clement, M., Sakharkar, M.
Format:	Journal Article
Published:	informa UK Ltd 2011
Online Access:	http://hdl.handle.net/20.500.11937/50187

Similar Items

In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach
by: Roney, Miah, et al.
Published: (2025)

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway
by: Woo, C., et al.
Published: (2011)

Targeting PPARy signaling cascade for the prevention and treatment of prostate cancer
by: Sikka, S., et al.
Published: (2012)

Identification of novel peroxisome proliferator-activated receptor-gamma (PPAR[gamma]) agonists using molecular modeling method
by: Kumar, Alan Prem
Published: (2014)

Triterpenoids and sesquiterpenoids for prostate cancer therapy
by: Shanmugam, M., et al.
Published: (2016)

NHE-1: A promising target for novel anti-cancer therapeutics
by: Loo, S., et al.
Published: (2012)

Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal Peroxisome Proliferator Activated Receptors (PPARα and PPARγ) gene expression in rats
by: Hajjar, Toktam, et al.
Published: (2012)

Ciglitazone inhibits growth and induces apoptosis in human colorectal cancer cell lines independently of PPARγ
by: Darus, Halisa Mohd, et al.
Published: (2004)

Elucidating hepatic lipidosis in stray cats through serum biochemistry, liver histopathology and liver RNA expression of PPAR-δ and PPAR-γ
by: F. Salleh,, et al.
Published: (2022)

Evaluation of the PPAR-γ agonist pioglitazone in mild asthma: a double-blind randomized controlled trial
by: Anderson, J.R., et al.
Published: (2016)

Synergism between cAMP and PPARγ signalling in the initiation of UCP1 gene expression in HIB1B brown adipocytes
by: Chen, H.Y., et al.
Published: (2013)

Prostatic diseases: is it toxic or genetic? Study of TNF alpha gene polymorphism and cigarette smoking in cases of prostate cancer and benign prostatic hyperplasia
by: M. Attalla, Sohayla, et al.
Published: (2016)

Application of Proteomics Approaches in the Identification of New Markers and Therapeutic Targets for Breast Cancer
by: Moh’d Hamadneh, Lama Abdel Qader
Published: (2008)

Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-y
by: Bharathkumar, H., et al.
Published: (2014)

Xanthones from Garcinia Malaccencis improve Glut4 aswell as decreased Pparγ activation on adipocytes
by: Bakhtiar, M. Taher, et al.
Published: (2013)

Role Of Peroxisome Proliferator Activated Receptor-γ ( PPARγ) Ligands On The Foam Cell Formation Derived From MNV-1 Infected Macrophages
by: Musa, Khirun
Published: (2017)

Evaluation of the PPAR-γ agonist pioglitazone in mild asthma: a double-blind randomized controlled trial
by: Leroyer, Christophe, et al.
Published: (2016)

PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
by: Chen, L., et al.
Published: (2017)

Haemodynamic Effects Of Adiponectin On PPAR–γ Receptors In Diabetic And Nondiabetic Wistar Kyoto And Spontaneously Hypertensive Rats
by: Afzal, Sheryar
Published: (2017)

Antiobesity effects of α-mangostin through glut4 and leptin expression together with pparγ activation in adipocytes
by: Bakhtiar, M. Taher, et al.
Published: (2013)

Association Of Peroxisome Proliferator-Activated Receptors (Ppars) Α, Γ And Δ Gene Polymorphisms With Obesity And Metabolic Syndrome In The Sub-Urban Kampar Population, Malaysia
by: Phee, Chia Phee
Published: (2015)

Identification of potential therapeutic targets for Streptococcus suis infection
by: Jeffreys, Bethan
Published: (2021)

An in silico approach for identification of potential therapeutic targets for cancer treatment from celastrus hindsii Benth
by: Nguyen, Van Huy, et al.
Published: (2024)

Molecular characterization of peroxisome proliferator activated receptor gamma2 (PPARγ2) promoter from bovine
by: Ismail, Ida Shazrina, et al.
Published: (2004)

Molecular characterization of peroxisome proliferator activated receptor gamma2 (PPARγ2) promoter from bovine
by: Ismail, Ida Shazrina, et al.
Published: (2004)

The expression of PPARS gamma in the cervical cancer line, hela and the effects of specific PPAR ligand on cell growth
by: Yaacob, Nik Soriani
Published: (2013)

The expression of ppars gamma in the cervical cancer line, bela and the effects of specific PPAR ligand on cell growth
by: Yaacob, Nik Soriani
Published: (2013)

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

The Effects Of Pioglitazone And MK886 ON THE Mrna EXPRESSION OF PPAR-alpha, PPAR-gamma And Its Associated GENES, Cell Death And Migration In MDA-MB- 231 Cancer Cells
by: Nadarajan, Kalpanah
Published: (2015)

Virtual screening of pyrazole derivatives of usnic acid as new class of anti-hyperglycemic agents against PPARγ agonists
by: Roney, Miah, et al.
Published: (2023)

Perfluorooctane sulfonate induces neuronal and oligodendrocytic differentiation in neural stem cells and alters the expression of PPARγ in vitro and in vivo
by: Wan Ibrahim, Wan Norhamidah, et al.
Published: (2013)

The Underlying molecular mechanism of bufei yishen prescription for copd in mice model based on NFR1/PPAR γ pathway
by: Xu, Cong
Published: (2024)

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
by: Banik, K., et al.
Published: (2018)

Unveiling potential therapeutic targets for breast cancer recurrence: differentially expressed genes and pathways in post-surgery patients
by: Hamad, Hamad Ali, et al.
Published: (2024)

Homology Modeling and Molecular Docking Studies on Type II Diabetes Complications Reduced PPARγ Receptor with Various Ligand Molecules
by: Prabhu, S., et al.
Published: (2017)

Therapeutic targeting of the leukaemia microenvironment
by: Kuek, V., et al.
Published: (2021)

Single nucleotide polymorphism of pparγ, enpp1 and capn-10 genes in type 2 diabetes mellitus patients with and without coronary artery disease in a Malaysian tertiary hospital / Darishiani Paramasivam
by: Darishiani, Paramasivam
Published: (2016)

Molecular targets and anti-cancer potential of escin
by: Cheong, D., et al.
Published: (2018)

Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways
by: Shanmugam, M., et al.
Published: (2012)

Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate cancer cell lines
by: Shun, Ying Quah, et al.
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h60q9oi4ud9k6qid1pglh94fe1